American Health Packaging has recalled 60 cartons of Lamivudine Tablets (150 mg), which is the generic version of Epivir used to treat HIV-1 and Hepatitis B. The recall was issued because the package insert incorrectly describes the tablets' appearance in the "Dosage Forms and Strengths" section. This labeling error could lead to confusion about whether the patient is taking the correct medication or dosage. The affected products were distributed nationwide in unit-dose blister packs. Consumers should contact their doctor or pharmacist to confirm they have the correct medication and return any products from the affected lots for a refund.
An incorrect physical description of the tablet in the package insert can cause patients or healthcare providers to misidentify the medication or its strength. This increases the risk of medication errors, potentially leading to improper dosing or missed treatments.
Refund and medical guidance
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.